drugset / Trial / NCT00819988

Pregabalin in the Prevention of Postoperative Delirium and Pain

NCT00819988

Phase 3 Completed 240 enrolled Ottawa Hospital Research Institute Pfizer · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether administration of pregabalin by mouth immediately preoperatively and three times daily for 3 days after surgery reduces the incidence of delirium postoperatively and improves overall pain control.

Timeline

Start
2009-05
Primary completion
2011-09
Completion
2011-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 25 mg Oral
Subject Pregabalin Small molecule 50 mg Oral

Indications